Dan is currently Chief Business Officer of Ventus Therapeutics. Previously Dan was Chief Business Officer at Arrakis Therapeutics and BIND Therapeutics and held positions at Biogen in Corporate Development, Discovery Research, and Commercial Operations. He founded and served as President of Biogen’s biosimilars business. Dan is deeply experienced in building high-growth organizations in the US and abroad, designing and implementing creative strategies to build corporate value, financing innovative companies from inception through IPO, negotiating and managing corporate collaborations, and leading groups of diverse functional experts. Dan received an MBA from Harvard Business School and a B.S. in Biochemistry from Boston College.